| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of 1 Pathology and 2 Clinical Ophthalmology, Institute of Ophthalmology, University College London; and Moorfields Eye Hospital, London, England.
PURPOSE. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP-3) gene have previously been identified in patients with Sorsby’s fundus dystrophy (SFD). We evaluated the ocular distribution of TIMP-3 and other extracellular constituents in SFD.
METHODS. The eyes of an SFD donor with a confirmed TIMP-3 mutation were examined using histologic techniques demonstrating connective tissue, calcium, and lipid. Immunohistochemical analyses were performed using antibodies against TIMP-3, collagen type IV, V, and VI, laminin, fibronectin, elastin, and fibrillin. Electron microscopy also was used.
RESULTS. A subretinal pigment epithelium (sub-RPE) deposit similar to that previously described was seen. A morphologically similar but different deposit was present internal to the nonpigmented ciliary epithelium (NPCE). Both deposits contained collagens, elastin, glycosaminoglycans, lipids, and calcium. Immunolabeling of TIMP-3 was found in the basement membrane of the NPCE, Bruch’s membrane, and choroidal vessels in normal control subjects. In SFD, immunolabeling of TIMP-3 also was present in the sub-RPE deposit and in the inner portion of the ciliary body deposit. TIMP-3 immunoreactivity was more extensive in the SFD eye. The pattern of elastin immunoreactivity was remarkably similar to that of TIMP-3. Electron microscopy revealed a morphologically altered elastic layer of the Bruch’s membrane.
CONCLUSIONS. Sub-RPE TIMP-3 immunoreactivity appears more extensive in SFD than in control subjects. There is also a correspondence between TIMP-3 and elastin immunoreactivies, which invites speculation as to a link between the SFD TIMP-3 mutation and altered elastin processing. The accumulation of abnormal material in SFD is more widespread than previously reported. In view of this, SFD might be better termed Sorsby’s ocular epitheliopathy.
This article has been cited by other articles:
|
|
 |
|
  N. Kondo, S. Honda, K. Ishibashi, Y. Tsukahara, and A. Negi Elastin Gene Polymorphisms in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1101 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A Majid, V. A Smith, A. C Newby, and A. D Dick Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3 Br. J. Ophthalmol., August 1, 2007; 91(8): 1073 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M A Majid, V A Smith, F J Matthews, A C Newby, and A D Dick Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane Br. J. Ophthalmol., October 1, 2006; 90(10): 1310 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Langton, N. McKie, B. M. Smith, N. J. Brown, and M. D. Barker Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells Hum. Mol. Genet., December 1, 2005; 14(23): 3579 - 3586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sivaprasad, N. V. Chong, and T. A. Bailey Serum Elastin-Derived Peptides in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3046 - 3051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.H. V. Chong, J. Keonin, P. J. Luthert, C. I. Frennesson, D. M. Weingeist, R. L. Wolf, R. F. Mullins, and G. S. Hageman Decreased Thickness and Integrity of the Macular Elastic Layer of Bruch's Membrane Correspond to the Distribution of Lesions Associated with Age-Related Macular Degeneration Am. J. Pathol., January 1, 2005; 166(1): 241 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Michaelides, D M Hunt, and A T Moore The genetics of inherited macular dystrophies J. Med. Genet., September 1, 2003; 40(9): 641 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. F. Weber, B. Lin, K. White, K. Kohler, G. Soboleva, S. Herterich, M. W. Seeliger, G. B. Jaissle, C. Grimm, C. Reme, et al. A Mouse Model for Sorsby Fundus Dystrophy Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2732 - 2740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Clarke, K. W Mitchell, J. Goodship, S. McDonnell, M. D Barker, I. D Griffiths, and N. McKie Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism Br. J. Ophthalmol., December 1, 2001; 85(12): 1429 - 1431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Stone, V. C. Sheffield, and G. S. Hageman Molecular genetics of age-related macular degeneration Hum. Mol. Genet., October 1, 2001; 10(20): 2285 - 2292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Jacobson, A. V. Cideciyan, E. Wright, and A. F. Wright Phenotypic Marker for Early Disease Detection in Dominant Late-Onset Retinal Degeneration Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1882 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. GREGORY-EVANS What is Sorsby's fundus dystrophy? Br. J. Ophthalmol., July 1, 2000; 84(7): 679 - 680. [Full Text]
|
|
|
|
|
|
C S SETHI, T A BAILEY, P J LUTHERT, and N H V CHONG Matrix metalloproteinase biology applied to vitreoretinal disorders Br. J. Ophthalmol., June 1, 2000; 84(6): 654 - 666. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
